Adam Mostafa
Director of Finance/CFO chez X4 PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Provenance du réseau au premier degré de Adam Mostafa
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Brown University
248
| College/University | Other Consumer Services | 248 |
CRT Capital Group LLC
 CRT Capital Group LLC Investment Banks/BrokersFinance Founded in 1989, CRT Capital Group LLC is an institutional securities research and brokerage firm located in Stamford, Connecticut. The firm focuses on high-yield and convertible debt, capital structure arbitrage, mergers and acquisitions, special situations and distressed securities. CRT trades senior and subordinated bonds, bank debt, trade claims, convertible bonds, equities, real estate loans, tax exempt securities and private placements.
121
| Extinct | Investment Banks/Brokers | 121 |
| Public Company | Biotechnology | 29 | |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market.
17
| Subsidiary | Investment Banks/Brokers | 17 |
AQR Capital Management LLC
 AQR Capital Management LLC Investment ManagersFinance AQR Capital Management LLC (AQR) is a SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. They are a wholly-owned subsidiary of AQR Capital Management Holdings LLC and their ultimate parent is AQR Capital Management Group LP. The firm was founded by Clifford Asness, David Kabiller, and John Liew in 1998. AQR provides investment management services to institutional clients through managed accounts. Their investors may include investment companies, pooled investment vehicles, pension and profit sharing plans, charitable organizations, state or municipal government entities, other investment advisers, insurance companies, sovereign wealth funds and foreign official institutions, corporations or other businesses entities.
10
| Subsidiary | Investment Managers | 10 |
| Private Company | Biotechnology | 6 | |
Precision Biologics, Inc.
 Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX.
6
| Subsidiary | Drugstore Chains | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Adam Mostafa via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BROWN-FORMAN CORPORATION | Beverages: Alcoholic | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Administrative Officer Director/Board Member | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Analyst-Fixed Income Corporate Officer/Principal Analyst-Fixed Income | |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Banks/Brokers | Director of Research - Fxd Inc Trading-Equity Analyst-Fixed Income | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
R. W. Pressprich & Co.
 R. W. Pressprich & Co. Investment Banks/BrokersFinance R. W. Pressprich & Co. (RWP) is an employee-owned institutional broker-dealer headquartered in New York City. Founded in 1909, RWP’s principal focus is to provide fixed-income relative value and market timing research for clients. | Investment Banks/Brokers | Director of Research - Equity Corporate Officer/Principal | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Banks/Brokers | Analyst-Equity Director of Research - Fxd Inc | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aetos Technologies, Inc.
 Aetos Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Aetos Technologies, Inc. is a technology development company. The firm offers funding and management services to commercialize and market technologies developed at research institutions. The company services include evaluation, product, process development, business management, and financing. Aetos Technologies was founded in 2003 and is headquartered in Auburn, AL. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal | |
| Vanderbilt University | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Therapeutic Antibodies, Inc.
 Therapeutic Antibodies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., Therapeutic Antibodies, Inc. is a biopharmaceutical company that specializes in research and development to produce polyclonal antibodies. The private company is based in Nashville, TN. Therapeutic Antibodies was acquired by Protherics Plc on September 15, 1999 for $38.46 million. | Miscellaneous Commercial Services | President Chief Administrative Officer | |
| York University | College/University | Undergraduate Degree Masters Business Admin | |
Lazard Asset Management LLC
 Lazard Asset Management LLC Investment ManagersFinance Lazard Asset Management LLC (LAM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1970 and is a wholly-owned subsidiary of Lazard Frères & Co. LLC, ultimately held by Lazard Ltd. (NYSE: LAZ). LAM provides investment advisory services to a variety of clients. | Investment Managers | Corporate Officer/Principal Analyst-Equity | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree | |
| Mississippi State University | College/University | Undergraduate Degree Masters Business Admin | |
| New York University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Graduate Degree | |
| McMaster University | College/University | Undergraduate Degree Doctorate Degree | |
Nashville Health Care Council
 Nashville Health Care Council Miscellaneous Commercial ServicesCommercial Services Part of Nashville Area Chamber of Commerce, Nashville Health Care Council operates as an association of health care industry leaders. The private company is based in Nashville, TN. The company was founded by Philip M. Hertik. | Miscellaneous Commercial Services | Director/Board Member Chairman President | |
Life Science Tennessee
 Life Science Tennessee Miscellaneous Commercial ServicesCommercial Services Life Science Tennessee operates tennessee biotechnology association. It conducts business and economic development activities. The firm advocates on behalf of the industry. It provides a network for the exchange of ideas, information and opportunities. The company is headquartered in Nashville, TN. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Aegis Sciences Corp.
 Aegis Sciences Corp. Miscellaneous Commercial ServicesCommercial Services Aegis Sciences Corp. engages in provision of forensic toxicology and consulting laboratory services. It offers Paincomp, Interact RX, Acurise ID, pre natal testing, sports testing, and Pharmacogenetic testing. The company was founded by David L. Black in 1990 and is headquartered in Nashville, TN. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Bryant University | College/University | Undergraduate Degree Undergraduate Degree | |
| INVIVYD, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Founder | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stem Cell Network | Corporate Officer/Principal Chairman | ||
| Cumberland Emerging Technologies, Inc. | Chief Executive Officer Director/Board Member | ||
| The Fletcher School | College/University | Graduate Degree Graduate Degree | |
Verio Therapeutics, Inc.
 Verio Therapeutics, Inc. BiotechnologyHealth Technology Part of Fate Therapeutics, Inc., Verio Therapeutics, Inc. is a Canadian pharmaceutical company that manufactures products for activating endogenous stem cells. The private company is based in Ottawa, Canada. Verio Therapeutics was acquired by Fate Therapeutics, Inc. on April 08, 2010. The company was founded by Frank Gleeson, Michael Rudnicki. | Biotechnology | Founder Founder | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 43 |
| Canada | 7 |
| France | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 19 |
| Consumer Services | 15 |
| Finance | 9 |
| Commercial Services | 8 |
| Consumer Non-Durables | 2 |
Opérationnelle
| Director/Board Member | 323 |
| Corporate Officer/Principal | 185 |
| Independent Dir/Board Member | 86 |
| Undergraduate Degree | 75 |
| Founder | 74 |
Relations les plus connectées
| Insiders | |
|---|---|
| Robert Langer | 88 |
| Franklin Berger | 41 |
| Michael Wyzga | 31 |
| Ruth Simmons | 27 |
| Joey Anthony Jacobs | 26 |
| Alison Lawton | 24 |
| Fred Driscoll | 21 |
| Joseph Galante | 16 |
| Gary Bridger | 16 |
| David McGirr | 16 |
| Michael B. Cross | 15 |
| A. Kazimi | 15 |
| Brian Bloom | 15 |
| Geoff MacKay | 15 |
| Warren Whitehead | 14 |
- Bourse
- Insiders
- Adam Mostafa
- Connexions Sociétés
